Ureteral Stents Market Scope, Growth, Trends and Opportunity 2024-2032

IMARC Group’s report titled "Ureteral Stents Market Report by Product Type (Open-End Stents, Closed-End Stents, Double J-Stent, Multiloop Stents), Material (Metallic Ureteral Stents, Polymer Ureteral Stents), Application (Kidney Stones, Kidney Transplantation, Tumors, Urinary Incontinence, and Others), End Use (Hospitals and Clinics, Ambulatory Surgical Centers (ASCs), and Others), and Region 2024-2032". The global ureteral stents market size reached US$ 374.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 606.5 Million by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032.

Grab a sample PDF of this report: https://www.imarcgroup.com/ureteral-stents-market/requestsample

Factors Affecting the Growth of the Ureteral Stents Industry:

Innovations, such as biodegradable stents, drug-eluting stents, and those with anti-reflux properties, are enhancing patient outcomes and comfort. Biodegradable stents eliminate the need for a second procedure to remove the stent, reducing the overall healthcare burden and improving patient convenience. Drug-eluting stents release medications that prevent complications like infections or encrustations, addressing common issues associated with traditional stents. Additionally, stents with anti-reflux designs minimize the backflow of urine are enhance patient comfort. These technological improvements make ureteral stents more effective, safer, and easier to use.

The increasing prevalence of urological disorders, such as kidney stones, urinary tract infections (UTIs), and strictures, among the masses is propelling the market growth. Conditions like nephrolithiasis or kidney stones often necessitate the use of ureteral stents to ensure the smooth passage of stones and prevent obstruction in the urinary tract. The growing incidence of these conditions is linked to lifestyle factors, dietary habits, and an aging population. The rising number of patients requiring treatment for these conditions is catalyzing the demand for ureteral stents, as they are a critical component in the management and resolution of obstructive uropathy.

Public health campaigns and educational initiatives by healthcare organizations emphasize the importance of early detection and management of urological conditions. Screening programs, particularly those targeting high-risk populations, help identify conditions like kidney stones, strictures, and tumors early when they are more easily treatable. Early diagnosis often necessitates the use of ureteral stents to manage urinary obstructions and prevent complications. The growing awareness about urological health is resulting in more individuals seeking medical attention for symptoms, including the use of ureteral stents.

Leading Companies Operating in the Global Ureteral Stents Industry:

Ureteral Stents Market Report Segmentation:

By Product Type:

Double J-stents exhibit a clear dominance in the market due to their widespread use and efficacy in treating ureteral obstructions and facilitating urine flow.

By Material:

Polymer ureteral stents (silicone stents, polyurethane stents, and hybrid stents) represent the largest segment owing to their flexibility, biocompatibility, and cost-effectiveness compared to metal stents.

By Application:

Kidney stones hold the biggest market share attributed to the increasing prevalence of kidney stones, which necessitate frequent use of ureteral stents for treatment and management.

By End Use:

Hospitals and clinics account for the majority of the market share accredited to the high volume of urological procedures performed in these settings requiring ureteral stent placement.

Regional Insights:

North America dominates the market on account of the advanced healthcare infrastructure, high prevalence of urological conditions, and rising healthcare expenditure.

Global Ureteral Stents Market Trends:

Advances in endoscopic and laparoscopic techniques are making it possible to treat urological conditions with less invasive methods, reducing patient recovery times and hospital stays. Ureteral stents are often used in conjunction with these procedures to ensure proper urinary drainage and prevent complications, such as ureteral obstruction or injury.

Additionally, the integration of smart technology into ureteral stents is offering a favorable market outlook. These smart stents are equipped with sensors that can monitor various physiological parameters, including urine flow and pressure, and transmit data to healthcare providers in real time. This continuous monitoring facilitates early detection of complications and allows for timely interventions, improving patient outcomes.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163